Related references
Note: Only part of the references are listed.Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE Trial
Lorenz Raeber et al.
CIRCULATION (2011)
Prospective Randomized Comparison of Sirolimus- or Everolimus-Eluting Stent to Treat Bifurcated Lesions by Provisional Approach
Francesco Burzotta et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Impact of the Everolimus-Eluting Stent on Stent Thrombosis A Meta-Analysis of 13 Randomized Trials
Usman Baber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Randomized Comparison of Everolimus- and Paclitaxel-Eluting Stents
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice
Pieter C. Smits et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial
Sigmund Silber et al.
LANCET (2011)
Endothelial cell recovery, acute thrombogenicity, and monocyte adhesion and activation on fluorinated copolymer and phosphorylcholine polymer stent coatings
Shawn L. Chin-Quee et al.
BIOMATERIALS (2010)
Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries
Christoph Kaiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents Two-Year Clinical Follow-Up From the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SPIRIT) III Trial
Gregg W. Stone et al.
CIRCULATION (2009)
Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions The SPIRIT II Trial
Bimmer E. Claessen et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Endothelial cell recovery between comparator polymer-based drug-eluting stents
Michael Joner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice -: 4-year results from a large 2-institutional cohort study
Peter Wenaweser et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease
Albert Schoemig et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Outcomes associated with drug-eluting and bare-metal stents:: a collaborative network meta-analysis
Christoph Stettler et al.
LANCET (2007)
Vascular responses to drug eluting stents - Importance of delayed healing
Aloke V. Finn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Clinical end points in coronary stent trials - A case for standardized definitions
Donald E. Cutlip et al.
CIRCULATION (2007)
Stent thrombosis in randomized clinical trials of drug-eluting stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious?
R Virmani et al.
CIRCULATION (2004)
Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the real world -: The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry
PA Lemos et al.
CIRCULATION (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
GW Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery
JW Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Statistics Notes - Interaction revisited: the difference between two estimates
DG Altman et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
E Grube et al.
CIRCULATION (2003)
Share Paper
